PGNY - Progyny Inc

PGNY - Progyny Inc

https://www.progyny.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Surging Earnings Estimates Signal Upside for Progyny ( PGNY ) Stock

Zacks Commentary • 2 weeks ago • score: 0.64

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CVS Health Corporation ( CVS ) Hit a 52 Week High, Can the Run Continue?

Zacks Commentary • 2 weeks ago • score: 0.37

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny ( PGNY ) Tops Q2 Earnings and Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.21

Progyny (PGNY) delivered earnings and revenue surprises of +9.09% and +3.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will Progyny ( PGNY ) Beat Estimates Again in Its Next Earnings Report?

Zacks Commentary • 1 month, 3 weeks ago • score: 0.51

Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - Progyny ( NASDAQ:PGNY )

Benzinga • 2 months ago • score: 0.65

NEW YORK, July 10, 2025 ( GLOBE NEWSWIRE ) -- Progyny, Inc. PGNY, a global leader in women's health and family building solutions, today announced a new partnership with ŌURA, maker of the world's leading smart ring, further empowering women to better understand and take action on their health ...

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

GlobeNewswire • 2 months ago • score: 0.64

NEW YORK, July 10, 2025 ( GLOBE NEWSWIRE ) -- Progyny, Inc. ( Nasdaq: PGNY ) , a global leader in women's health and family building solutions, today announced a new partnership with ŌURA, maker of the world's leading smart ring, further empowering women to better understand and take action on ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Progyny, Inc., a benefits management company, specializes in fertility benefits and family development solutions for employers in the United States. The company is headquartered in New York, New York.

52W High

$26.76

52W Low

$13.39

MA Status:

50D: Below 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.33

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

38.22

Forward P/E (<15 better)

11.44

EV/EBITDA (<8 favorable)

20.54

EV/Revenue (<3 favorable)

1.34

P/S (TTM) (<3 favorable)

1.56

P/B (<3 favorable)

3.77

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

7.60%

Institutions (25–75% balanced)

103.80%

Shares Outstanding

85,982,000

Float

79,602,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,241,968,000

Gross Profit (TTM)

277,444,000

EPS (TTM)

0.59

Profit Margin (>10% good)

0.04%

Operating Margin (TTM) (higher better)

0.07%

ROE (TTM) (>15% strong)

0.11%

EPS YoY (Quarterly) (>10% good)

0.12

Revenue YoY (Quarterly) (>8% good)

0.10

Momentum

Bearish momentum

Value

-0.0377

Previous

0.0204

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025